IAM retention and blood brain barrier penetration

Author： Ducarme A.   Neuwels M.   Goldstein S.   Massingham R.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.33, Iss.3, 1998-03, pp. : 215-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to assess blood–brain barrier penetration

By Di Li   Kerns Edward H   Carter Guy T  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 677-687

Informa Healthcare

Access to resources Recommend Favorite

Blood–Brain Barrier Penetration of Zolmitriptan—Modelling of Positron Emission Tomography Data

By Bergström Mats   Yates Roger   Wall Anders   Kågedal Matts   Syvänen Stina   Långström Bengt  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 1, 2006-02 ,pp. : 75-91

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of Blood-Brain Barrier Penetration: In Silico, In Vitro and In Vivo

By  

Current Drug Metabolism, Vol. 3, Iss. 6, 2002-12 ,pp. : 647-657

Bentham Science Publishers

Access to resources Recommend Favorite

Transporter-Based Delivery of Anticancer Drugs to the Brain: Improving Brain Penetration by Minimizing Drug Efflux at the Blood-Brain Barrier

By  

Current Pharmaceutical Design, Vol. 20, Iss. 10, 2014-03 ,pp. : 1499-1509

Bentham Science Publishers

Access to resources Recommend Favorite

Selecting Good ‘Drug-Like’ Properties to Optimize Small Molecule Blood-Brain Barrier Penetration

By  

Current Medicinal Chemistry, Vol. 23, Iss. 14, 2016-04 ,pp. : 1392-1407

Bentham Science Publishers

Access to resources Recommend Favorite